External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score

Gynecologic Oncology

Volumn 110, Issue 3, 2008, Pages 354-359

  Brun, Jean Luc ^a   Rouzier, Roman ^a,b   Uzan, Serge ^a,b   Daraï, Emile ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Cytoreductive surgery; Laparoscopy; Ovarian cancer; Resectability

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCURACY; ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; DIAPHRAGM DISEASE; DIAPHRAGMATIC CARCINOSIS; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; LAPAROSCOPY; LAPAROTOMY; LIVER METASTASIS; OVARY CANCER; PERITONEAL CARCINOSIS; PERITONEUM CANCER; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LAPAROSCOPY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 50149114455     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.04.042     Document Type: Article

References (16)

1. Griffiths C.T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42 (1975) 101-104
2. Chi D.S., Liao J.B., Leon L.F., et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 82 (2001) 532-537
3. Kuhn W., Rutke S., Spathe K., et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics stage IIIC ovarian carcinoma. Cancer 92 (2001) 2581-2591
4. Dowdy S., Mullany S., Brandt K., Huppert B., and Cliby W. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in patients with advanced ovarian carcinoma. Cancer 101 (2004) 346-352
5. Martinez-Said H., Rincon D.G., Montes De Oca M.M., Ruiz G.C., Ponce J.L.A., and Lopez-Graniel C.M. Predictive factors for irresectability in advanced ovarian cancer. Int J Gynecol Cancer 14 (2004) 423-430
6. Bristow R.E., Duska L., Lambrou N., et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89 (2000) 1532-1540
7. Dowdy S., Mullany S., Brandt K., Huppert B., and Cliby W. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in patients with advanced ovarian carcinoma. Cancer 101 (2004) 346-352
8. Fagotti A., Ferrandina G., Fanfani F., Ercoli A., Lorusso D., Rossi M., et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 13 (2006) 1156-1161
9. Vergote I., De Wever I., Tjalma W., Van Gramberen M., Decloedt J., and van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 71 (1998) 431-436
10. Angioli R., Palaia I., Zullo M.A., Muzii L., Manci N., Calcagno M., et al. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol 100 (2006) 45-61
11. Fagotti A., Fanfani F., Ludovisi M., Lo Voi R., Bifulco G., Testa A.C., et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol 96 (2005) 729-735
12. Aletti G.D., Dowdy S.C., Podratz K.C., and Cliby W.A. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 197 (2007) 676.e1-676.e7
13. Bristow R.E., Eisenhauer E.L., Santillan A., and Chi D.S. Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol Oncol 104 (2007) 480-490
14. Bristow R.E., and Chi D.S. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol Oncol 103 (2006) 1070-1076
15. Clough K.B., Ladonne J.M., Nos C., Renolleau C., Validire P., and Durand J.C. Second look for ovarian cancer: laparoscopy or laparotomy? A prospective comparative study. Gynecol Oncol 72 (1999) 411-417
16. Deffieux X., Castaigne D., and Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. Int J Gynecol Cancer 16 Suppl1 (2006) 35-40